author-photo

Fiona Brown

Ohio State University

5

Papers

4

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

PRMT5 Inhibition Promotes FOXO1 Tumor Suppressor Activity to Drive a Pro-Apoptotic Program That Creates Vulnerability to Combination Treatment with Venetoclax in Mantle Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
PRMT5 INHIBITION RESTARTS A PRO-APOPTOTIC PROGRAM AND CREATES VULNERABILITY TO COMBINATION TREATMENT WITH BCL-2 INHIBITOR VENETOCLAX IN MANTLE CELL LYMPHOMA

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PRMT5 Inhibition Drives Therapeutic Vulnerability to BCL-2 Inhibition with Venetoclax and Provides Rationale for Combination Therapy in Mantle Cell Lymphoma

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Targeting PRMT5 to Circumvent Acquired Ibrutinib Resistance in Mantle Cell Lymphoma

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)